MongoDB heads into tonight's earnings report having already handed investors a brutal month — and the question is whether the selling is finished or just beginning.
The stock closed at $334.68 on Monday, down 25% over the past month and off 18% in the last week alone. That kind of pre-earnings drawdown is unusual. It arrives with a stock that was trading near $450 as recently as mid-August. The collapse happened fast. Notably, options traders are not particularly defensive into the print: the put/call ratio sits at 0.60, slightly below its 20-day average of 0.61 and well inside its 52-week range. That's a call-leaning setup, not a fearful one — suggesting the buyers of options are positioning for a bounce rather than bracing for further damage.
The short-selling community is telling a different story, but a measured one. Short interest runs at 3.4% of the free float, up 25% over the past month in share terms, yet still well below the levels that would signal a crowded short. Borrow conditions are extremely loose — availability runs above 8,000%, meaning there is no shortage of supply for anyone wanting to initiate a new short position. Cost to borrow has roughly doubled over the past month to 0.61%, though in absolute terms that remains trivial. The ORTEX short score has drifted lower over September, from around 34.7 to 33.2, moving away from any territory that would flag elevated short-side conviction. Short interest alone does not explain the collapse in price.
The analyst community was enthusiastically bullish after MDB's last earnings print on September 1 — Goldman Sachs raised its target to $520, Citigroup lifted to $565, and most of the Street followed with upward revisions. The consensus mean target now sits at $454, implying roughly 36% upside from Monday's close. Yet those targets were set when the stock was trading $100–$130 higher. The September 1 print itself was the story: MDB fell 17% on the day and extended to a 21% loss over the following five sessions. The stock has not recovered. EPS momentum ranks in the 92nd percentile on a 30-day basis, and the analyst recommendation differential ranks in the 94th percentile across the ORTEX universe — so the fundamental case, in the Street's telling, remains intact. Bears will argue that the market is pricing in something the consensus has not yet reset for: whether that's competitive pressure on the core Atlas platform, slower cloud database workload growth, or AI-native alternatives displacing MongoDB's document architecture.
On the institutional side, FMR (Fidelity) added over 1.4 million shares in the most recent reporting period, making them one of the largest holders at roughly 4.4% of shares. BlackRock also recently added, while Vanguard's consolidated entity reported a material stake around 10.5% in aggregate. Insider activity is less encouraging — director Dwight Merriman sold over $13.7 million in shares over the 90-day window, all under pre-arranged 10b5-1 plans, which limits the signal but registers as a directional note.
Tonight's print tests whether MDB's rapid deterioration from $450 to $334 has cleared the bar, or whether the Street's bullish consensus still needs a more meaningful reset.
See the live data behind this article on ORTEX.
Open MDB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
